We serve Chemical Name:2-Bromo-6-chloro-3-pyridinamine CAS:1050501-88-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-6-chloro-3-pyridinamine
CAS.NO:1050501-88-6
Synonyms:2-Bromo-6-chloro-3-pyridinamine;2-Bromo-6-chloropyridin-3-amine;3-Pyridinamine, 2-bromo-6-chloro-
Molecular Formula:C5H4BrClN2
Molecular Weight:207.456
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:330.3±37.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.648
PSA:38.91000
Exact Mass:205.924637
LogP:2.12
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Bromo-6-chloro-3-pyridinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Pyridinamine, 2-bromo-6-chloro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyridinamine, 2-bromo-6-chloro- Use and application,2-Bromo-6-chloro-3-pyridinamine technical grade,usp/ep/jp grade.
Related News: Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. 2-Bromo-6-chloro-3-pyridinamine manufacturer New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. 2-Bromo-6-chloro-3-pyridinamine supplier At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. 2-Bromo-6-chloro-3-pyridinamine vendor Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. 2-Bromo-6-chloro-3-pyridinamine factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.
